Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.

Members of the APOBEC3 family of deoxycytidine deaminases counteract a broad range of retroviruses in vitro through an indirect mechanism that requires virion incorporation and inhibition of reverse transcription and/or hypermutation of minus strand transcripts in the next target cell. The selective...

Full description

Bibliographic Details
Main Authors: Diana S Smith, Kejun Guo, Bradley S Barrett, Karl J Heilman, Leonard H Evans, Kim J Hasenkrug, Warner C Greene, Mario L Santiago
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-10-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC3188525?pdf=render
_version_ 1818529505675837440
author Diana S Smith
Kejun Guo
Bradley S Barrett
Karl J Heilman
Leonard H Evans
Kim J Hasenkrug
Warner C Greene
Mario L Santiago
author_facet Diana S Smith
Kejun Guo
Bradley S Barrett
Karl J Heilman
Leonard H Evans
Kim J Hasenkrug
Warner C Greene
Mario L Santiago
author_sort Diana S Smith
collection DOAJ
description Members of the APOBEC3 family of deoxycytidine deaminases counteract a broad range of retroviruses in vitro through an indirect mechanism that requires virion incorporation and inhibition of reverse transcription and/or hypermutation of minus strand transcripts in the next target cell. The selective advantage to the host of this indirect restriction mechanism remains unclear, but valuable insights may be gained by studying APOBEC3 function in vivo. Apobec3 was previously shown to encode Rfv3, a classical resistance gene that controls the recovery of mice from pathogenic Friend retrovirus (FV) infection by promoting a more potent neutralizing antibody (NAb) response. The underlying mechanism does not involve a direct effect of Apobec3 on B cell function. Here we show that while Apobec3 decreased titers of infectious virus during acute FV infection, plasma viral RNA loads were maintained, indicating substantial release of noninfectious particles in vivo. The lack of plasma virion infectivity was associated with a significant post-entry block during early reverse transcription rather than G-to-A hypermutation. The Apobec3-dependent NAb response correlated with IgG binding titers against native, but not detergent-lysed virions. These findings indicate that innate Apobec3 restriction promotes NAb responses by maintaining high concentrations of virions with native B cell epitopes, but in the context of low virion infectivity. Finally, Apobec3 restriction was found to be saturable in vivo, since increasing FV inoculum doses resulted in decreased Apobec3 inhibition. By analogy, maximizing the release of noninfectious particles by modulating APOBEC3 expression may improve humoral immunity against pathogenic human retroviral infections.
first_indexed 2024-12-11T17:07:44Z
format Article
id doaj.art-c55e999576e74449a8b3de8fc049b487
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-11T17:07:44Z
publishDate 2011-10-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-c55e999576e74449a8b3de8fc049b4872022-12-22T00:57:38ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742011-10-01710e100228410.1371/journal.ppat.1002284Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.Diana S SmithKejun GuoBradley S BarrettKarl J HeilmanLeonard H EvansKim J HasenkrugWarner C GreeneMario L SantiagoMembers of the APOBEC3 family of deoxycytidine deaminases counteract a broad range of retroviruses in vitro through an indirect mechanism that requires virion incorporation and inhibition of reverse transcription and/or hypermutation of minus strand transcripts in the next target cell. The selective advantage to the host of this indirect restriction mechanism remains unclear, but valuable insights may be gained by studying APOBEC3 function in vivo. Apobec3 was previously shown to encode Rfv3, a classical resistance gene that controls the recovery of mice from pathogenic Friend retrovirus (FV) infection by promoting a more potent neutralizing antibody (NAb) response. The underlying mechanism does not involve a direct effect of Apobec3 on B cell function. Here we show that while Apobec3 decreased titers of infectious virus during acute FV infection, plasma viral RNA loads were maintained, indicating substantial release of noninfectious particles in vivo. The lack of plasma virion infectivity was associated with a significant post-entry block during early reverse transcription rather than G-to-A hypermutation. The Apobec3-dependent NAb response correlated with IgG binding titers against native, but not detergent-lysed virions. These findings indicate that innate Apobec3 restriction promotes NAb responses by maintaining high concentrations of virions with native B cell epitopes, but in the context of low virion infectivity. Finally, Apobec3 restriction was found to be saturable in vivo, since increasing FV inoculum doses resulted in decreased Apobec3 inhibition. By analogy, maximizing the release of noninfectious particles by modulating APOBEC3 expression may improve humoral immunity against pathogenic human retroviral infections.http://europepmc.org/articles/PMC3188525?pdf=render
spellingShingle Diana S Smith
Kejun Guo
Bradley S Barrett
Karl J Heilman
Leonard H Evans
Kim J Hasenkrug
Warner C Greene
Mario L Santiago
Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
PLoS Pathogens
title Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
title_full Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
title_fullStr Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
title_full_unstemmed Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
title_short Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
title_sort noninfectious retrovirus particles drive the apobec3 rfv3 dependent neutralizing antibody response
url http://europepmc.org/articles/PMC3188525?pdf=render
work_keys_str_mv AT dianassmith noninfectiousretrovirusparticlesdrivetheapobec3rfv3dependentneutralizingantibodyresponse
AT kejunguo noninfectiousretrovirusparticlesdrivetheapobec3rfv3dependentneutralizingantibodyresponse
AT bradleysbarrett noninfectiousretrovirusparticlesdrivetheapobec3rfv3dependentneutralizingantibodyresponse
AT karljheilman noninfectiousretrovirusparticlesdrivetheapobec3rfv3dependentneutralizingantibodyresponse
AT leonardhevans noninfectiousretrovirusparticlesdrivetheapobec3rfv3dependentneutralizingantibodyresponse
AT kimjhasenkrug noninfectiousretrovirusparticlesdrivetheapobec3rfv3dependentneutralizingantibodyresponse
AT warnercgreene noninfectiousretrovirusparticlesdrivetheapobec3rfv3dependentneutralizingantibodyresponse
AT mariolsantiago noninfectiousretrovirusparticlesdrivetheapobec3rfv3dependentneutralizingantibodyresponse